View Document Preview and Link Document Date: 2013-12-31 12:40:12 Open Document File Size: 542,99 KB Share Result on Facebook
Company Formal SPA / Clinical Trials Group / GM / / Event FDA Phase / / Facility Cancer Research National Cancer Institute / Laboratory of Tumor Immunology / / MedicalCondition prior vaccinia experience / disease / Minimally Symptomatic Metastatic Castration Resistant Prostate Cancer / smallpox / fowlpox rF / Prostate Cancer / Vaccinia / vaccinia naïve / / MedicalTreatment vaccination / / Organization Cancer Research National Cancer Institute / FDA / National Institute of Health / Laboratory of Tumor Immunology and Biology Senior / Medical Oncology Branch Center / / Position Investigator / physician / F.A.C.P. Director / Deputy Chief / / Product Pox Vector Vaccine / HS1 / / SocialTag 
PROSTVAC Presentation for the RAC James L. Gulley M.D., Ph.D., F.A.C.P. Director, Clinical Trials Group & Deputy Chief, Laboratory of Tumor Immunology and Biology